Resource-based cancer care, including co-existing health problems of HIV and cancer, to be addressed at Nairobi conference

Class in: Sant
Topics : Non-profit, FVT

The international collaboration to improve cancer outcomes in sub-Saharan Africa is working to update harmonized consensus guidelines on several key oncology topics, including how best to treat people with both cancer and HIV.

NAIROBI, Kenya, May 1, 2024 /PRNewswire/ — Local and international experts come together NairobiAt Kenyato update clinical practice guidelines as part of ongoing work with Allied Against Cancer – a collaboration between the National Comprehensive Cancer Network (NCCN), African Cancer Coalition (ACC), American Cancer Society (ACS) and Clinton Health Access Initiative (CHAI). The conference brings together subject matter experts to update the NCCN Harmonized Guidelines™ for sub-Saharan Africa, including cancer treatment in people with HIV and other important topics. The event takes place from May 1 to 3, 2024.

The NCCN Harmonized Guidelinestm for sub-Saharan Africa are available free of charge on the website NCCN.org/harmonizedor via theappfrom the Virtual Library NCCN Guidelines (NCCN guidelines).

The published guidelines have a direct impact on improving cancer treatment for people living with HIV by alleviating fears of drug interactions and confirming the safety and necessity of commonly used treatments, said Professor WarrenPhipps, Medical Director, Uganda Cancer Institute? Fred Hutch Collaboration. Many cancers occur more commonly in people with HIV and AIDS, including AIDS-related cancers such as non-Hodgkin’s lymphoma, Kaposi’s sarcoma, and invasive cervical cancer. Non-AIDS-classifying cancers are also increasing in this population as AIDS treatment improves, leading to longer life expectancy. Sub-Saharan Africa is disproportionately affected by HIV/AIDS, making it particularly necessary to have region-specific guidelines.

The NCCN Harmonized Guidelinestm use color-coded recommendations to delineate the best possible cancer care in various settings and based on resource availability. They are based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), expert consensus recommendations based on evidence maintained by multidisciplinary panels of leading clinicians and researchers. Allied Against Cancer is committed to updating these tailored guidelines at least every two years, meeting with local oncologists in sub-Saharan Africa to share their expertise and experience.

These meetings provide us with unique and productive opportunities to share knowledge between different countries and specialties, said Professor ShanthiSivendran, vice president of cancer care support, American Cancer Society. By standardizing treatment approaches based on the latest evidence, we can ensure that patients receive optimal care. These guidelines also provide a blueprint for how best to increase capacity in areas where resources are limited.

The conference of Nairobi will focus on updates to the NCCN Harmonized Guidelines™ for people living with HIV, as well as the following cancer types:

  • Breast cancer
  • Kaposi’s sarcoma
  • Malignant pleural mesothlioma
  • Non-small cell lung cancer
  • Cancer of unknown primary (cancer of unknown primary origin)
  • Prostate cancer
  • Small cell lung cancer
  • Thymomas and thymic carcinomas

The group will also update the NCCN Harmonized Guidelines™ focused on prevention and supportive care, including:

  • Screening and diagnosis of breast cancer
  • Prevention and treatment of cancer-related infections
  • Early detection of prostate cancer

The teacher William J. GradisharRobert H. Lurie Comprehensive Cancer Center of Northwestern UniversityChairman of the NCCN Guidelines Expert Group for Breast Cancer is attending the meeting, as well as Professor Gregory J. RielyMemorial Sloan Kettering Cancer Center, Chair of the NCCN Guidelines Panel for Non-Small Cell Lung Cancer/Mesothelioma/Thymomas and Thymic Carcinomas and Professor ManojP.MenonFred Hutch Cancer Center, who is a member of the NCCN guidelines panels for cancer in people with HIV and Kaposi’s sarcoma.

The NCCN harmonized guidelines illustrate our commitment to advancing cancer care and reducing global disparities in cancer access and outcomes, said Professor Crystal S. Denlinger, Director General of the NCCN. We hope that their continued use and implementation leads to tangible and steady improvements in cancer prevention and treatment in sub-Saharan Africa and contributes to better health outcomes for people across the region.

The NCCN Harmonized Guidelines™ for sub-Saharan Africa were endorsed by federal ministries of health and major cancer centers in Ethiopia, LiberiaAt MalawiAt Nigeria, in Tanzania, Uganda and Zambia, or 44% of the population of sub-Saharan Africa. To learn more about Allied Against Cancer’s efforts to improve cancer outcomes, visitalliesagainstcancer.org.

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network(NCCN) is a non-profit alliance of leading cancer centersdedicated to patient care, research and education. The NCCN is dedicated to improving and facilitating the quality, efficiency, equity and accessibility of cancer care so that all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide transparent, evidence-based recommendations and expert consensus for cancer treatment, prevention and support services. They are the recognized standard for clinical guidance and policy in cancer management and the most comprehensive and frequently updated clinical practice guidelines available in all areas of medicine. The NCCN Guidelines for Patients provide specialist cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation. The NCCN also encourages continuing education, global initiatives, policy, research collaboration and publication in the field of oncology. Visit the siteNCCN.orgto know more.

About the American Cancer Society
The American Cancer Society is a leading cancer organization with a vision to end cancer as we know it, for everyone. For over 100 years, we have been improving the lives of people with cancer and their families as the only organization fighting cancer through advocacy, research and patient support. We are committed to ensuring that everyone has the opportunity to prevent, detect, treat and survive cancer. To find out more, visitcancer.orgor call our 24-hour helpline at 1-800-227-2345. Stay in touch with us onFacebook, TwitterAndInstagram.

Media Contact:
RachelDarwin
267-622-6624
[email protected]

Photo – https://mma.prnewswire.com/media/2398229/National_Comprehensive_Cancer_Network_Meeting.jpg

Logo –https://a-a-4-en.e24n.com/en/wp-content/uploads/2024/05/Resource-based-cancer-care-including-co-existing-health-problems-of-HIV-and.jpg

These press releases may also interest you

03:06

Local and international experts gather in Nairobi, Kenya, to update clinical practice guidelines in…

00:35

The city of Suzhou in east China’s Jiangsu Province on Friday held a global investment promotion conference themed Investing Suzhou for a Mutually Beneficial Future, which culminated in the…

00:33

A report from China Daily: The ZGC2024 Forum held in Beijing presented a wide range of the latest technological innovations. The event, which took place from April 25 to 29, included 128 activities, including forums and…

00:24

A report from China Daily: The ZGC2024 Forum in Beijing presented a wide range of the latest technological innovations. The event took place from April 25 to 29 and included 128 activities, including forums and conferences, exchanges…

Apr 30, 2024

OMRONHealthcareCo., Ltd. Based in Muko, Kyoto Prefecture, Japan, announces that it is the official sponsor of May Measurement Month (MMM), a global campaign to raise awareness of blood pressure screening and promote prevention,…

Apr 30, 2024

SpinEM Robotics, a deeptech startup specializing in cutting-edge navigation solutions for robotic spine surgery, is delighted to announce that it has reached a significant milestone in its innovation journey. The company has…

Communiqué sent on May 1, 2024 03:06 and distributed by:
93bf6e4c0e.jpg

-

-

PREV Whole-body MRI: beware of false promises
NEXT Woman survives five cancers with 11 fewer organs